Routine atrial fibrillation cardioversion? No;Fibrillazione atriale: Cardiovertire sempre? Parere contro

Italian Heart Journal Supplement

Volumn 3, Issue 1, 2002, Pages 81-90

  Di Pasquale, Giuseppe ^a   Biancoli, Stefano ^a   Sassone, Biagio ^a   Pancaldi, Leonardo G ^a  

^a Ospedale di Bentivoglio   (Italy)

Author keywords

Antiarrhythmic drug prophylaxis; Atrial fibrillation; Electrical cardioversion; Oral anticoagulant therapy

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT;

ANTICOAGULATION; CARDIOVERSION; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEART FUNCTION; HEART SIZE; HUMAN; PROPHYLAXIS; RECURRENT DISEASE; REVIEW; SINUS RHYTHM; TREATMENT INDICATION;

AGE FACTORS; ATRIAL FIBRILLATION; ELECTRIC COUNTERSHOCK; HUMANS; RECURRENCE;

EID: 0036208565     PISSN: 11294728     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (60)

1. Epidemiologic features of chronic atrial fibrillation
2. Prevalence of atrial fibrillation in elderly subjects (The Cardiovascular Health study)
3. Atrial fibrillation: Current knowledge and recommendations for management
4. Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study
5. Studio FIRE (Atrial Fibrillation Italian Registry): Caratteristiche e risultati epidemiologici generali di carattere generale
6. "Cardioversion" of atrial fibrillation: A report on the treatment of 65 episodes in 50 patients
7. Optimal technique for electrical cardioversion of atrial fibrillation
8. Higher energy synchronized external direct current cardioversion for refractory atrial fibrillation
9. Double external direct-current shocks for refractory atrial fibrillation
10. Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment
11. Transthoracic cardioversion of atrial fibrillation. Comparison of rectilinear versus damped sine wave monophasic shocks
12. Low energy atrial cardioversion in atrial fibrillation lasting more than a year
13. Multicenter low energy transvenous atrial defibrillation (XAD) trial. Results in different subjects of atrial fibrillation
14. Low-energy intracardiac cardioversion after failed conventional external cardioversion of atrial fibrillation
15. Safety and efficacy of low-energy cardioversion of 500 patients using two different techniques
16. Acute treatment of atrial fibrillation: Why and when to maintain sinus rhythm
17. Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy
18. Cost-effective management of acute atrial fibrillation: Role and rate control, spontaneous conversion, medical and direct current cardioversion, transesophageal echocardiography, and antiembolic therapy
19. Atrial fibrillation begets atrial fibrillation: A study in awake chronically instrumented goats
20. Electrical remodeling of the human atrium: Similar effects in patients with chronic atrial fibrillation and atrial flutter
21. Atrial enlargement as a consequence of atrial fibrillation. A prospective echocardiographic study
22. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: Analysis of pooled data from five randomized controlled trials
23. Risk factors for thromboembolism in patients with paroxysmal atrial fibrillation
24. Stroke with intermittent atrial fibrillation: Incidence and predictors during aspirin therapy
25. Long-term antithrombotic therapy in atrial fibrillation: When anticoagulant and when antiplatelet agents?
26. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: A meta-analysis
27. The impairment of health-related quality of life in patients with intermittent atrial fibrillation: Implications for the assessment of investigational therapy
28. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion: A meta-analysis of randomized controlled trials
29. Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation
30. Amiodarone to prevent recurrence of atrial fibrillation
31. Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation
32. Cost-effective strategies in the acute management of atrial fibrillation
33. Perspectives and controversies in atrial fibrillation
34. Quando rinunciare alla cardioversione e rassegnarsi alla fibrillazione atriale stabile?
35. Management of atrial fibrillation: The need for AFFIRMative action
36. Pilot study and protocol of the Canadian Trial of Atrial Fibrillation
37. Rhythm or rate control in atrial fibrillation - Pharmacological Intervention in Atrial Fibrillation (PIAF): A randomised trial
38. Clinical trials update: CAPRICORN, COPERNICUS, MIRACLE, STAF, RITZ-2, RECOVER and RENAISSANCE and cachexia and cholesterol in heart failure. Highlights of the Scientific Sessions of the American College of Cardiology, 2001
39. Echocardiographic and clinical predictors for outcome of elective cardioversion of atrial fibrillation
40. Maintenance of sinus rhythm after atrial defibrillation
41. Electroshock for atrial flutter and atrial fibrillation. Follow-up studies on 50 patients
42. Long-term outcome in patients with chronic atrial fibrillation after successful internal cardioversion
43. Chronic atrial fibrillation
44. Factors determining maintenance of sinus rhythm after chronic atrial fibrillation with left atrial dilatation
45. Patient characteristics and underlying heart disease as predictors of recurrent atrial fibrillation after internal and external cardioversion in patients treated with oral sotalol
46. Restoration and maintenance of sinus rhythm after mitral valve surgery for mitral stenosis
47. Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter
48. Factors influencing long-term persistence of sinus rhythm after a first electrical cardioversion for atrial fibrillation
49. Recurrence of paroxysmal atrial fibrillation or flutter after successful cardioversion in patients with normal left ventricular function
50. Low dose amiodarone for maintenance of sinus rhythm after cardioversion of atrial fibrillation or flutter
51. Efficacy and safety of flecainide acetate in the maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation or flutter
52. Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion for chronic atrial fibrillation or flutter
53. Transesophageal echocardiographic predictors for maintenance of sinus rhythm after electrical cardioversion of atrial fibrillation
54. Systemic review of the management of atrial fibrillation in patients with heart failure
55. Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients
56. Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation. Observations from the Veterans Affairs Congestive Heart Failure Survival Trial of Antiarrhythmic Therapy (CHF-STAT)
57. Lack of prevention of heart failure by serial electrical cardioversion in patients with persistent atrial fibrillation
58. Cardioversion of atrial fibrillation in the setting of mild-to-moderate heart failure
59. The impact of patients' preferences on the treatment of atrial fibrillation: Observational study of patient based decision analysis
60. Quando non prescrivere un trattamento cronico al paziente con fibrillazione atriale